Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity

• Published in: Toxicology and applied pharmacology Vol. 228; no. 3; pp. 295 - 300
• Main Authors: Kang, Jin Seok, Wanibuchi, Hideki, Morimura, Keiichirou, Wongpoomchai, Rawiwan, Chusiri, Yaowares, Gonzalez, Frank J., Fukushima, Shoji
• Format: Journal Article
• Language: English
• Published: San Diego, CA Elsevier Inc 01.05.2008; Elsevier
• Subjects: 60 APPLIED LIFE SCIENCES; ALANINES; ALKALINE PHOSPHATASE; Animals; Biological and medical sciences; Body Weight - drug effects; CYP2E1; Cyp2e1-null mice; Cytochrome P-450 CYP2E1 - physiology; FIBROSIS; GLUTATHIONE; HEMORRHAGE; Hepatotoxicity; INFLAMMATION; LACTATE DEHYDROGENASE; Lipid Peroxidation - drug effects; LIPIDS; LIVER; Liver - drug effects; Liver - metabolism; Liver - pathology; LIVER CELLS; Male; Medical sciences; METABOLIC ACTIVATION; MICE; MIXED-FUNCTION OXIDASES; NECROSIS; NITRIC OXIDE; Organ Size - drug effects; OXIDATION; Oxidative stress; PEROXIDASES; RATS; Reverse Transcriptase Polymerase Chain Reaction; Thioacetamide (TAA); Thioacetamide - toxicity; Toxicology; Oxidative stress; AST; ALT; FMO; MDA; GPx; IL-6; LDH; TNF-α; Cyp2e1-null mice; TAA; ROS; iNOS; MFOs; CYP; CYP2E1; Hepatotoxicity; Thioacetamide (TAA); Digestive system; Enzyme; Toxicity; Cytochrome P450; Liver; Rodentia; Hepatic disease; Vertebrata; Mammalia; Mouse; Animal; Digestive diseases
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1016/j.taap.2007.11.010

Previous experiments showed that treatment of mice and rats with thioacetamide (TAA) induced liver cell damage, fibrosis and/or cirrhosis, associated with increased oxidative stress and activation of hepatic stellate cells. Some experiments suggest that CYP2E1 may be involved in the metabolic activation of TAA. However, there is no direct evidence on the role of CYP2E1 in TAA-mediated hepatotoxicity. To clarify this, TAA-induced hepatotoxicity was investigated using Cyp2e1-null mice. Male wild-type and Cyp2e1-null mice were treated with TAA (200 mg/kg of body weight, single, i.p.) at 6 weeks of age, and hepatotoxicity examined 24 and 48 h after TAA treatment. Relative liver weights of Cyp2e1-null mice were significantly different at 24 h compared to wild-type mice ( p < 0.01). Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) in Cyp2e1-null mice were significantly different at both time points compared to wild-type mice ( p < 0.01). Histopathological examination showed Cyp2e1-null mice represented no hepatototoxic lesions, in clear contrast to severe centriobular necrosis, inflammation and hemorrhage at both time points in wild-type mice. Marked lipid peroxidation was also only limited to wild-type mice ( p < 0.01). Similarly, TNF-α, IL-6 and glutathione peroxidase mRNA expression in Cyp2e1-null mice did not significantly differ from the control levels, contrasting with the marked alteration in wild-type mice ( p < 0.01). Western blot analysis further revealed no increase in iNOS expression in Cyp2e1-null mice. These results reveal that CYP2E1 mediates TAA-induced hepatotoxicity in wild-type mice as a result of increased oxidative stress.